TY - JOUR T1 - Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment JF - European Respiratory Review JO - EUROPEAN RESPIRATORY REVIEW SP - 472 LP - 486 DO - 10.1183/16000617.0063-2016 VL - 25 IS - 142 AU - Anna C. Bibby AU - Selina Tsim AU - Nikolaos Kanellakis AU - Hannah Ball AU - Denis C. Talbot AU - Kevin G. Blyth AU - Nick A. Maskell AU - Ioannis Psallidas Y1 - 2016/12/01 UR - http://err.ersjournals.com/content/25/142/472.abstract N2 - Malignant pleural mesothelioma is an aggressive malignancy of the pleural surface, predominantly caused by prior asbestos exposure. There is a global epidemic of malignant pleural mesothelioma underway, and incidence rates are predicted to peak in the next few years.This article summarises the epidemiology and pathogenesis of malignant pleural mesothelioma, before describing some key factors in the patient experience and outlining common symptoms. Diagnostic approaches are reviewed, including imaging techniques and the role of various biomarkers. Treatment options are summarised, including the importance of palliative care and methods of controlling pleural effusions. The evidence for chemotherapy, radiotherapy and surgery is reviewed, both in the palliative setting and in the context of trimodality treatment. An algorithm for managing malignant pleural effusion in malignant pleural mesothelioma patients is presented. Finally new treatment developments and novel therapeutic approaches are summarised.This article on mesothelioma describes pathogenesis, symptoms, diagnostic approaches and treatment options http://ow.ly/cjkb305aQGz ER -